BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29467480)

  • 1. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
    Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
    Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study.
    Andreasen S; Tan Q; Agander TK; Hansen TVO; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; Heegaard S; Wessel I; Homøe P
    Virchows Arch; 2018 Sep; 473(3):329-340. PubMed ID: 30069755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.
    Emerick C; Mariano FV; Vargas PA; Nör JE; Squarize CH; Castilho RM
    Crit Rev Oncol Hematol; 2022 Nov; 179():103792. PubMed ID: 35973662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
    Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
    J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.
    Togashi Y; Dobashi A; Sakata S; Sato Y; Baba S; Seto A; Mitani H; Kawabata K; Takeuchi K
    Mod Pathol; 2018 Jun; 31(6):934-946. PubMed ID: 29410490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
    Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
    Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
    Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
    Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
    Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MicroRNA-profiling in breast- and salivary gland-derived adenoid cystic carcinomas].
    Kiss O; Tőkés AM; Spisák S; Szilágyi A; Lippai N; Szász AM; Kulka J
    Orv Hetil; 2013 Jun; 154(25):963-8. PubMed ID: 23774803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational landscape of lacrimal gland carcinomas and implications for treatment.
    Bell D; Sniegowski MC; Wani K; Prieto V; Esmaeli B
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E724-E729. PubMed ID: 25899808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
    West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
    Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
    Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
    Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.
    Koo JS; Yoon JS
    Am J Clin Pathol; 2015 Apr; 143(4):584-92. PubMed ID: 25780012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
    von Holstein SL
    Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
    Fusco N; Geyer FC; De Filippo MR; Martelotto LG; Ng CK; Piscuoglio S; Guerini-Rocco E; Schultheis AM; Fuhrmann L; Wang L; Jungbluth AA; Burke KA; Lim RS; Vincent-Salomon A; Bamba M; Moritani S; Badve SS; Ichihara S; Ellis IO; Reis-Filho JS; Weigelt B
    Mod Pathol; 2016 Nov; 29(11):1292-1305. PubMed ID: 27491809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoid Cystic Carcinoma With Striking Tubular Hypereosinophilia: A Unique Pattern Associated With Nonparotid Location and Both Canonical and Novel EWSR1::MYB and FUS::MYB Fusions.
    Weinreb I; Rooper LM; Dickson BC; Hahn E; Perez-Ordonez B; Smith SM; Lewis JS; Skalova A; Baněčková M; Wakely PE; Thompson LDR; Rupp NJ; Freiberger SN; Koduru P; Gagan J; Bishop JA
    Am J Surg Pathol; 2023 Apr; 47(4):497-503. PubMed ID: 36920022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
    Butcher MR; White MJ; Rooper LM; Argani P; Cimino-Mathews A
    Am J Surg Pathol; 2022 Jul; 46(7):878-888. PubMed ID: 35522890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.
    Kiss O; Tőkés AM; Spisák S; Szilágyi A; Lippai N; Székely B; Szász AM; Kulka J
    Pathol Oncol Res; 2015 Jan; 21(1):29-44. PubMed ID: 25240490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.